DLA PIPER UK LLP (Belgium)

Lobbying Organisation DLA PIPER UK LLP (Belgium)

Date published 14 May, 2024

Relevant Matter Public policy or programme

Public Policy Area EU Affairs

Period 1 Jan, 2024 to 30 Apr, 2024

Specific Details Administrative procedure (EMA)

Intended results A letter was drafted to inform the MEP about the non-pharmacovigilance procedure.

Name of person primarily responsible for lobbying on this activity Richard Sterneberg

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? Yes

Client(s)

Client 1

Company name Currax Pharmaceuticals LLC

CRO number (if applicable)

Company address 155 Franklin Rd, Suite 450 Brentwood, TN 37027

Main business or activity

Company website

Contact email address info@curraxpharma.com

Contact phone number 800-793-2145

Contact address

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Email (2-5)

DLA Piper emailed the office of MEP Kelleher to set up a meeting with its client, Currax Pharmaceuticals LLC, concerning the non-pharmacovigilance procedure at the EU level. Due to conflicting schedules, the meeting did not take place. DLA Piper subsequently emailed the office of MEP Kelleher to inform him of Currax Pharmaceuticals LLC’s position regarding the procedure.

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Billy Kelleher MEP (European Parliament)